See also this year's filing and all EDGAR filings for this company.
PDF Report 0001017491_2013_Seelos_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001017491, Seelos Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 20,895,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 601,000 |
| 3 | remainder_Assets | 2,383,000 |
| 4 | LiabilitiesCurrent | 10,766,000 |
| 5 | LiabilitiesNoncurrent | 196,000 |
| 6 | remainder_Liabilities | 6,296,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,377,000 |
| 9 | ResearchAndDevelopmentExpense | 5,375,000 |
| 10 | remainder_Expenses | 13,074,000 |
| 11 | remainder_Revenues | 8,416,000 |
| 12 | remainder_NetIncome | -6,361,000 |
| 13 | remainder_ComprehensiveNetIncome | 641,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 23,879,000 |
| 1 | Liabilities | 17,258,000 |
| 2 | Expenses | 33,826,000 |
| 3 | Revenues | 8,416,000 |
| 4 | StockholdersEquity | 6,621,000 |
| 5 | NetIncome | -31,771,000 |
| 6 | ComprehensiveNetIncome | -31,450,500 |
| 7 | BaseVar | 45,190,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.827 |
| 9 | EconomicCapitalRatio | 1.34 |